PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland
Abstract
Authors
T.R. Einarson H. Pudas R. Zilbershtein R. Jensen A.T. Nielsen C. Piwko M. Hemels C. Vincente